Hanmi Pharmaceutical Group's year-long family feud over management control is poised to end, as a pivotal share transfer shifts power within the founding family. From left: Shin Dong-kuk, chairman ...

KOSPI struggles to maintain gains as semiconductor stocks drop after Huangs remarks KOSPI faces challenges as major tech ...

Foreign investors keep net-purchasing streak despite disappointment over chip stocks Korean shares gained on Tuesday with the ...

A year-long management dispute within the Hanmi Pharmaceutical Group family is nearing resolution. The conflict began in January when the group’s consolidation plan with OCI Group triggered a rift ...

Wildfires are continuing to devastate California, leaving thousands displaced and first responders stretched to their limits.

Hanmi Bank LOS ANGELES, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report fourth ...

LOS ANGELES, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report ...

LOS ANGELES, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), today announced that Hanmi Bank opened its first representative office in Seoul ...

Eli Lilly has opted to end a phase 2 rheumatoid arthritis (RA) trial of a drug it is developing with Korea’s Hanmi Pharmaceuticals, according to press reports. The Korea Biomedical Review cited ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...